US86366E1064
US86366E1064
Structure Therapeutics Inc.
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 1.82B EUR | 11.44B EUR | 10.28B EUR | 14.78B EUR |
Enterprise Value | 494.09M EUR | 11.18B EUR | 9.97B EUR | 13.99B EUR |
Valuation Multiples | ||||
Trailing P/E | -- | -- | -- | -- |
Forward P/E | -12.09x | -- | -- | -- |
Price to Sales | -- | -- | -- | -- |
Price to Book | 1.34x | 8.45x | 7.1x | 9.75x |
EV/Revenue | -- | -- | -- | -- |
EV/EBITDA | -1.86x | -- | -- | -- |
Price to FCF (P/FCF) | -- | -- | -- | -- |
EV/FCF | -- | -- | -- | -- |
FCF Yield | -6.54% | -1.96% | -1.55% | -1.17% |